Statements (56)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
gptkb:OSI_Pharmaceuticals
gptkb:Astellas_Pharma_US,_Inc. Ilypsa,_Inc. |
| gptkbp:employs |
Thousands of employees
|
| gptkbp:engagesIn |
Clinical trials
|
| gptkbp:focusesOn |
Oncology
Transplantation Urology Neurology Infectious diseases |
| gptkbp:foundedIn |
2005
|
| gptkbp:hasProductLine |
Cardiology
Gastroenterology Immunology Pain management Women's health Ophthalmology Endocrinology Hematology Vaccines Dermatology Respiratory Men's health |
| gptkbp:hasResearchFocus |
Cell therapy
Gene therapy Health economics Nanotechnology Regenerative medicine Biomarkers Precision medicine Pharmaceutical sciences Regulatory affairs Biologics Pharmacogenomics Patient-reported outcomes Small molecules Health technology assessment Market access strategies Outcomes research Quality of life studies Real-world evidence Clinical pharmacology Artificial intelligence in drug discovery Compliance and ethics in research Digital_health |
| gptkbp:headquarteredIn |
gptkb:Northbrook,_Illinois
|
| https://www.w3.org/2000/01/rdf-schema#label |
Astellas US LLC
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:offers |
Prescription medications
|
| gptkbp:operatesIn |
gptkb:United_States
|
| gptkbp:parentCompany |
gptkb:Astellas_Pharma_Inc.
|
| gptkbp:partnerships |
Various healthcare organizations
|
| gptkbp:provides |
Research and development services
|
| gptkbp:sponsor |
Patient assistance programs
|
| gptkbp:website |
www.astellas.com/us
|